| 14951-8 | Volatile drugs positive (screen method) | DRUG/TOX |
| 14952-6 | Xylose --1 hour post 25 g xylose PO (Blood) | CHAL |
| 14953-4 | Xylose --2 hours post 25 g xylose PO (Blood) | CHAL |
| 14954-2 | Xylose in 5 hour Urine --post dose PO | CHAL |
| 14955-9 | Zinc | DRUG/TOX |
| 14956-7 | Microalbumin in 24 hour Urine | CHEM |
| 14957-5 | Microalbumin (Urine) | CHEM |
| 14958-3 | Microalbumin/Creatinine in 24 hour Urine | CHEM |
| 14959-1 | Microalbumin/Creatinine (Urine) | CHEM |
| 1496-9 | Glucose --1.5 hours post 75 g glucose PO | CHAL |
| 14960-9 | Estradiol (E2) Free/Estradiol (E2).total | CHEM |
| 14961-7 | CD10 Abnormal blood cells/Abnormal blood cells.total (Blood) | CELLMARK |
| 14962-5 | CD13 Abnormal blood cells/Abnormal blood cells.total (Blood) | CELLMARK |
| 14963-3 | CD14 Abnormal blood cells/Abnormal blood cells.total (Blood) | CELLMARK |
| 14964-1 | CD19 Abnormal blood cells/Abnormal blood cells.total (Blood) | CELLMARK |
| 14965-8 | CD2 Abnormal blood cells/Abnormal blood cells.total (Blood) | CELLMARK |
| 14966-6 | CD20 Abnormal blood cells/Abnormal blood cells.total (Blood) | CELLMARK |
| 14967-4 | CD33 Abnormal blood cells/Abnormal blood cells.total (Blood) | CELLMARK |
| 14968-2 | CD5 Abnormal blood cells/Abnormal blood cells.total (Blood) | CELLMARK |
| 14969-0 | CD7 Abnormal blood cells/Abnormal blood cells.total (Blood) | CELLMARK |
| 1497-7 | Glucose --1.5 hours post dose insulin IV | CHAL |
| 14970-8 | Estrone (E1).bioavailable | CHEM |
| 14971-6 | Estrone (E1).bioavailable/Estrone (E1).total | CHEM |
| 14972-4 | Mycobacterium sp DNA (CSF, qualitative, naa with probe detection) | MICRO |
| 14973-2 | Mycobacterium sp DNA in Sputum (qualitative, naa with probe detection) | MICRO |
| 14974-0 | Mycobacterium sp DNA in Specimen (qualitative, naa with probe detection) | MICRO |
| 14975-7 | Human antimouse Ab | SERO |
| 14976-5 | Lecithin/Sphingomyelin (Amniotic Fluid) | CHEM |
| 14977-3 | Immunoglobulin light chains.free (Urine) | CHEM |
| 14978-1 | cycloSPORINE (Blood, immunoassay) | DRUG/TOX |
| 14979-9 | aPTT in Platelet poor plasma (coagulation assay) | COAG |
| 1498-5 | Glucose --10 minutes post 0.5 g/kg glucose IV | CHAL |
| 14980-7 | A variant subtype Ab from Blood product unit (qualitative) | BLDBK |
| 14981-5 | A variant subtype Ab from Donor (qualitative) | BLDBK |
| 14982-3 | A variant subtype Ab (qualitative) | BLDBK |
| 14983-1 | I (intermediate) subtype on Red Blood Cells from Blood product unit (qualitative) | BLDBK |
| 14984-9 | I (intermediate) subtype on Red Blood Cells from Donor (qualitative) | BLDBK |
| 14985-6 | I (intermediate) subtype on Red Blood Cells (qualitative) | BLDBK |
| 14986-4 | little i-1 subtype on Red Blood Cells from Blood product unit (qualitative) | BLDBK |
| 14987-2 | little i-1 subtype on Red Blood Cells from Donor (qualitative) | BLDBK |
| 14988-0 | little i-1 subtype on Red Blood Cells (qualitative) | BLDBK |
| 14989-8 | little i-2 subtype on Red Blood Cells from Blood product unit (qualitative) | BLDBK |
| 1499-3 | Glucose --1 hour post 0.5 g/kg glucose IV | CHAL |
| 14990-6 | little i-2 subtype on Red Blood Cells from Donor (qualitative) | BLDBK |
| 14991-4 | little i-2 subtype on Red Blood Cells (qualitative) | BLDBK |
| 14992-2 | O group on Red Blood Cells from Blood product unit (qualitative) | BLDBK |
| 14993-0 | O group on Red Blood Cells from Donor (qualitative) | BLDBK |
| 14994-8 | O group on Red Blood Cells (qualitative) | BLDBK |
| 14995-5 | Glucose --2 hours post 75 g glucose PO | CHAL |
| 14996-3 | Glucose --pre 75 g glucose PO | CHAL |